| |
|
|
|
Soleno Therapeutics Inc.  
|
|
2.35 0.3 (0.15%) |
03-21 16:00 |
|
Open: |
2.19 |
Pre close: |
2.05 |
Target:
|
4.15
|
|
High: |
2.55 |
Low: |
2.1133 |
Resistance:
|
3.56
5.07
|
|
Volume: |
2,020,550 |
Market Cap: |
75M |
Support:
|
1.11
0.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.39
 |
MACD |
MACD(12,26):
|
0.16 |
|
MA(20): |
1.74 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
1.81 |
Stochastic Oscillator |
%K(14,3):
|
28.20  |
|
MA(250): |
2.02 |
%D(3): |
31.26 |
|
Average Volume(K) |
3-Month: |
156397
|
52-Week |
High:
|
5.07 |
|
10-Days: |
913174 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
62.24 |
Change(%): |
24.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-99.6 |
Shares Out. (M) |
31.71 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-65.1 |
Shares Float (M) |
30.69 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.20 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
49.60 |
|
Forward EPS |
-0.791 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.420 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.69 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.68 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.35 |
P/CF |
-6.98 |
|
|
|
|
|
|
